Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations
  • Norton Cancer Institute /ID# 149788 Louisville, Kentucky, United States
  • St. Agnes Cancer Center /ID# 149782 Baltimore, Maryland, United States
  • Hackensack Univ Med Ctr /ID# 151574 Hackensack, New Jersey, United States
  • Utah Cancer Specialists /ID# 151604 Salt Lake City, Utah, United States
View all 67 locations
View Trial Details
Completed

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01256398

Conditions
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Hematologic Diseases, +10 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Rocky Mountain Cancer Centers-Boulder Boulder, Colorado, United States
View all 101 locations
View Trial Details
Completed

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

NCT03310190

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • University of Calgary /ID# 166416 Calgary, Alberta, Canada
  • Cross Cancer Institute /ID# 166417 Edmonton, Alberta, Canada
  • Jack Ady Cancer Centre /ID# 217491 Lethbridge, Alberta, Canada
  • CancerCare Manitoba /ID# 170751 Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Completed

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

NCT02185781

Conditions
Acute Lymphoblastic Leukemia, Complete Hematologic Remission (CHR), Hematologic Diseases, +15 more
Locations
  • ISS/AIFA Roma, Italy
  • Ospedale S. Eugenio Roma, Italy
  • Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

NCT02061761

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Local Institution - 0007 Baltimore, Maryland, United States
  • Local Institution - 0004 Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Local Institution - 0010 St Louis, Missouri, United States
View Trial Details

Related conditions